Oncothyreon Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 59   

Articles published

ONTY 1.80 -0.04 (-2.17%)
price chart
Why Biotech Stocks Jumped? - BioCryst Pharmaceuticals, Inc. (BCRX ...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) and Oncothyreon Inc (USA) (NASDAQ:ONTY) following small-cap stocks higher. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) extended gains as ...
Related articles »  
Stock Talk: Oncothyreon Inc (USA) (NASDAQ:ONTY), Penn West Petroleum Ltd ...
Denver, CO, 09/19/2014, (Avauncer.com) - Oncothyreon Inc (USA)(NASDAQ:ONTY) on Thursday announced that, it will set the prices for its previous underwritten offerings of 10, 000,000 shares on its common Stock at $2.00 per share.
Related articles »  
Stocks Roundup - Oncothyreon Inc (USA) (NASDAQ:ONTY), SPYGLASS ...
Oncothyreon Inc (USA) (NASDAQ:ONTY)closed latest trading day at $1.71, down-3.39%, on volume of over 673,426shares. Its average trading volume is 833,792shares.
Moving Stocks: Oncothyreon Inc (NASDAQ:ONTY), Baidu Inc (ADR) (NASDAQ ...
Oncothyreon Inc. (NASDAQ:ONTY) announced that Merck KGaA's (MRK) biopharmaceutical business, Merck Serono, developing its antigen-specific cancer immunotherapy, tecemotide (previously known as Stimuvax).
Related articles »  
Oncothyreon Receives Average Rating of "Buy" from Brokerages (NASDAQ:ONTY)
On average, analysts predict that Oncothyreon will post $-0.44 earnings per share for the current fiscal year. Oncothyreon Inc (NASDAQ:ONTY) is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for ...
Oncothyreon Inc - Market Review
NEW YORK (AVAFIN) -- Options traders were heavily trading options contracts during the market session establishing a new 3-month volume record for shares of Oncothyreon Inc. A total of 3,905 put and 3,020 calls were traded equating to a 1.29 put/call ...
Related articles »  
Microcap Stocks Lagged: Endocyte (NASDAQ:ECYT), Oncothyreon Inc ...
On September 22, 2014, in connection with the public offering of 10,000 shares of the Company's Series A Convertible Preferred Stock, Oncothyreon Inc. (NASDAQ:ONTY) designated 10,000 shares of its authorized and unissued preferred stock as Series A ...
Related articles »  
Oncothyreon Receives New Coverage from Analysts at HC Wainwright (ONTY)
Oncothyreon Inc logo Equities research analysts at HC Wainwright began coverage on shares of Oncothyreon (NASDAQ:ONTY) in a research note issued to investors on Tuesday, TheFlyOnTheWall.
Related articles »  
Recent Investment Analysts' Ratings Updates for Oncothyreon (ONTY)
Oncothyreon is now covered by analysts at Wedbush. They set a �buy� rating and a $4.00 price target on the stock. They wrote, �We are initiating coverage of Oncothyreon Inc. with a Buy rating and a 12-month target price of $4, based on a risk-adjusted ...
Wainwright Begins Coverage on Oncothyreon (ONTY)
Oncothyreon Inc logo Research analysts at Wainwright started coverage on shares of Oncothyreon (NASDAQ:ONTY) in a report released on Tuesday.
Oncothyreon Coverage Initiated at Wedbush (ONTY)  Watch List News (press release)
Oncothyreon Research Coverage Started at HC Wainwright (ONTY)  sleekmoney
Related articles »